Zydus Lifesciences Limited (ZYDUSLIFE.NS) NSE

986.50

-2.3(-0.23%)

Updated at August 18 03:30PM

Currency In INR

Valuation

Market Cap883.06B
Enterprise Value885.63B
P/E Ratio21.93
PEG Ratio51.69
Price/Sales Ratio4.32
Price/Book Ratio4.14
Enterprise/Revenue4.33
Enterprise/EBITDA13.67

Fiscal Year

Fiscal YearMarch 31, 2025
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.2
Operating Margin0.34

Management Effectiveness

Return On Assets0.12
Return On Equity0.2

Income Statement

Revenue232.42B
Revenue/Share228.37
Gross Profit169.04B
EBITDA68.95B
Net Income45.26B
Diluted EPS44.97

Balance Sheet

Total Cash78.08B
Total Cash/Share77.62
Total Debt32.13B
Total Debt/Equity0.13
Current Ratio1.89
Book Value Per Share262.03

Price History

52-Week Change-16.75
52-Week High1,220
52-Week Low795
Moving Average 50 Days972.22
Moving Average 200 Days938.37

Statistics

Average Volume993,396
Shares Outstanding1.01B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate11
Trailing Annual Dividend Yield1.12
Payout Ratio0
Last Split Factor5:1
Last Split DateOctober 06, 2015